Table 1.
Baseline clinical and demographic characteristics of patients evaluated for kidney transplant at time of RCC diagnosis.
| Total Patients | n = 21 (%) | |
|---|---|---|
| Age at first RCC diagnosis (years) | Years (median, IQR) | 54.4 (38.5 to 64.0) |
| Sex | Female | 6 (28.6) |
| Male | 15 (71.4) | |
| Race and Ethnicity | Non-Hispanic White | 13 (61.9) |
| Non-Hispanic Black | 4 (19.0) | |
| Hispanic | 3 (14.3) | |
| Asian | 1 (4.8) | |
| RCC Histology per Individual Patient | Clear Cell RCC | 10 (47.6) |
| Papillary RCC | 8 (38.1) | |
| Clear Cell RCC and Papillary RCC | 2 (9.5) | |
| Bilateral Papillary RCC | 1 (4.8) | |
| Anatomic Stage at first RCC Diangosis | I | 18 (85.7) |
| II | 0 | |
| III | 1 (4.8) | |
| IV | 1 (4.8) | |
| Kidney Dysfunction at first RCC Diagnosis | CKD Stage 3b | 1 (4.8) |
| CKD Stage 4 | 1 (4.8) | |
| CKD Stage 5 | 1 (4.8) | |
| ESRD on dialysis | 10 (47.6) | |
| Post-kidney transplant | 8 (38.1) | |
| Dialysis Prior to first RCC Diangosis | Yes | 16 (76.2) |
| No | 5 (23.8) | |
| Time on Dialysis (months) | Median (IQR) | 64.7 (36.8 to 92.3) |
RCC, renal cell carcinoma; CKD, chronic kidney disease; ESRD, end-stage renal disease; IQR, interquartile range.